B-hCLDN3/hCLDN4 mice

C57BL/6-Cldn3tm1(CLDN3)Bcgen Cldn4tm1(CLDN4)Bcgen/Bcgen • 111299

B-hCLDN2 mice
B-hCLEC10A mice

B-hCLDN3/hCLDN4 mice

Product nameB-hCLDN3/hCLDN4 mice
Catalog number111299
Strain nameC57BL/6-Cldn3tm1(CLDN3)Bcgen Cldn4tm1(CLDN4)Bcgen/Bcgen
Strain backgroundC57BL/6
AliasesC7orf1, CPE-R2, CPETR2, HRVP1, RVP1;CPE-R, CPER, CPETR, CPETR1, WBSCR8, hCPE-R

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis

Posters

View All

    Publication

      Related Products

      View All
      Description
      • Claudin family is a kind of tight junction proteins discovered in recent years. The changes of claudins directly affect the structure and function of tight junctions. Claudins are the main skeleton protein of the important membrane junction complex between tightly connected cells.
      • Clostridium perfringens enterotoxin (CPE) is a natural ligand of claudin-3 (CLDN3) and claudin-4 (CLDN4). CLDN3 is highly expressed in human esophageal cancer, epithelial ovarian cancer and other cancer tissues. CPE can effectively inhibit malignant tumors expressed by CLDN3, which provides the possibility for CLDN3 to be used as a targeted therapy for malignant tumors. CLDN3 is not only expressed in various human gland cells such as prostate, pancreas and liver cells, but also in mammary epithelial cell, endometrium, esophageal mucosa, alveolar epithelium and biliary epithelial cell.
      • In ovarian cancer, overexpression of CLDN4 induces epithelial-mesenchymal transition through the PI3K/Akt and Twist1 signal pathway. In pancreatic cancer, TGF-β can negatively regulate the expression of CLDN4, and the high expression of CLDN4 can inhibit tumor cell invasion. In breast cancer, CLDN4 promotes tumor cell migration and invasion through the PAK4-CEBPB-CLDN4 axis.
      • Mouse Cldn3 and Cldn4 mRNA were detectable in colon of wild-type C57BL/6 mice. Human CLDN3 and CLDN4 mRNA were detectable in colon of B-hCLDN3/hCLDN4 mice.
      • CLDN3 was detected in lung and colon of both wild-type C57BL/6 mice and homozygous B-hCLDN3/hCLDN4 mice, as anti-CLDN3 antibody was cross-reactive between human and mouse. Human CLDN4 was exclusively detectable in lung and colon of homozygous B-hCLDN3/hCLDN4 mice.
      • Application: This product is used for pharmacodynamics and safety evaluation of tumor and other autoimmune diseases.
      Tageting strategy

      Gene targeting strategy for B-hCLDN3/hCLDN4 mice.
      Mouse Cldn3 and Cldn4 gene were replaced by human CLDN3 and CLDN4 gene in B-hCLDN3/hCLDN4 mice.

      Protein expression analysis

      Western blot analysis of CLDN3 and CLDN4 protein expression in homozygous B-hCLDN3/hCLDN4 mice. Various tissue lysates were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hCLDN3/hCLDN4 mice (H/H, H/H), and then analyzed by western blot with cross-reactive anti-CLDN3 antibody or species-specific anti-CLDN4 antibody. 40 μg total proteins were loaded for western blotting analysis. CLDN3 and CLDN4 were detected in lung and colon.

      mRNA expression analysis

      Strain specific analysis of CLDN3 and CLDN4 mRNA expression in wild-type C57BL/6 mice and B-hCLDN3/hCLDN4 mice by RT-PCR. Colon RNA was isolated from wild-type C57BL/6 mice (+/+) and homozygous B-hCLDN3/hCLDN4 mice (H/H, H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human CLDN3 or CLDN4 primers. Mouse Cldn3 and Cldn4 mRNA were detectable only in wild-type C57BL/6 mice. Human CLDN3 and CLDN4 mRNA were detectable only in homozygous B-hCLDN3/hCLDN4 mice but not in wild-type mice.